Skip to main content
Premium Trial:

Request an Annual Quote

Iffmedic Marketing Multiplicom MDx Kits in Central Europe

NEW YORK (GenomeWeb News) – Iffmedic will market and sell Multiplicom's molecular diagnostic kits in Central Europe under a deal announced by the companies today.

Under the terms of the deal, the companies will co-promote Multiplicom's products, close sales agreements, and provide support to customers in Germany, Austria, and Eastern Europe. Multiplicom had already been selling its products in Germany.

Financial terms were of the deal not disclosed.

Based in Germany, Iffmedic sells in vitro diagnostic products in Central Europe and has more than a decade of experience in positioning molecular companion diagnostics, it said.

Multiplicom, spun out of the University of Antwerp and life sciences research institute VIB in 2011, is based in Belgium and develops, manufactures, and commercializes genetic tests based on molecular diagnostic technologies. In April 2011, it announced it had raised $3 million in financing.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.